AI-generated summary
This review compares data from meta-analyses and more recent trials on therapies that may help patients with major depressive disorder reach and sustain full remission. The authors report that venlafaxine as initial treatment was associated with higher remission rates than some other antidepressants, and that psychotherapy, exercise, light therapy and other approaches showed benefits over placebo, particularly when combined with medication.
- Who or what was studied
- Patients with major depressive disorder
- Limits stated in the abstract
- The abstract does not report the number of studies or participants included, and it does not describe the quality or certainty of the evidence reviewed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.